Amarin Corporation plc (ADR)
General ticker "AMRN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $200.6M
Amarin Corporation plc (ADR) does not follow the US Stock Market performance with the rate: -35.3%.
Estimated limits based on current volatility of 3.8%: low 0.45$, high 0.48$
Factors to consider:
- Current price 10.7% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.50$, 1.29$]
- 2024-12-30 to 2025-12-30 estimated range: [0.56$, 1.41$]
Financial Metrics affecting the AMRN estimates:
- Negative: Non-GAAP EPS, $ of -0.02 <= 0.10
- Negative: Operating profit margin, % of -18.05 <= 1.03
- Negative: Operating cash flow per share per price, % of 2.08 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0.14
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term AMRN quotes
Long-term AMRN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $583.19MM | $369.19MM | $306.91MM |
| Operating Expenses | $572.68MM | $475.06MM | $374.50MM |
| Operating Income | $10.50MM | $-105.87MM | $-67.59MM |
| Non-Operating Income | $0.79MM | $2.06MM | $13.92MM |
| Interest Expense | $0.13MM | $0.01MM | $0.01MM |
| R&D Expense | $29.31MM | $30.41MM | $22.22MM |
| Income(Loss) | $11.29MM | $-103.81MM | $-53.67MM |
| Taxes | $3.56MM | $2.00MM | $5.44MM |
| Profit(Loss) | $7.73MM | $-105.80MM | $-59.11MM |
| Stockholders Equity | $667.10MM | $595.33MM | $552.10MM |
| Inventory | $234.68MM | $228.73MM | $258.62MM |
| Assets | $1,068.07MM | $886.18MM | $831.68MM |
| Operating Cash Flow | $-66.54MM | $-180.09MM | $6.88MM |
| Capital expenditure | $0.00MM | $0.60MM | $0.53MM |
| Investing Cash Flow | $104.10MM | $175.29MM | $-25.52MM |
| Financing Cash Flow | $-5.07MM | $-0.38MM | $0.23MM |
| Earnings Per Share* | $0.02 | $-0.26 | $-0.15 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.